Editor-in-Chief, The Lancet Digital Health

Location: London, UK
Job Type: Full-Time
Employer: Elsevier
Responsible for developing and launching a new monthly online-only, gold open access specialty journal for The Lancet. The Editor must be a subject expert who can shape the journal into a forum for publishing the most relevant and practice-changing research in the multidisciplinary field of digital health.

The Lancet Digital Health will publish peer-reviewed Research Articles, Commentaries, editorials and other material that will contribute to advancing digital health worldwide. Responsibilities will include arranging peer review, commissioning, writing, and other activities involved in producing an online journal to a monthly schedule. Some foreign travel will be required.

The Editor-in-Chief will also be responsible for the day-to-day management of a Senior Editor.

Candidates for the role will ideally have an MD (with clinical experience in a relevant discipline) or a PhD (in a related subject); research experience in the specialty is necessary, as in an understanding of editorial processes and journal production. Experience of launching a new journal and of managing an editorial team would be an advantage.

Apply for this job

About Elsevier

Elsevier is a global information analytics business specializing in science and health.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...